Figure 1.
EGR2, FBXW7, RPS15, and FOXO1 mutations were shown to be associated with shorter treatment-free survival (TFS) in 86 patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.